Consolidated Statements of Stockholders' Equity - USD ($)	Total	Previously Reported [Member]	Series E Convertible Preferred Stock [Member]	Series B, C, D, E Convertible Preferred Stock [Member] Previously Reported [Member]	Series B, C, D, E Convertible Preferred Stock [Member] Revision of Prior Period, Adjustment [Member]	Old Ginkgo Common Stock [Member] Previously Reported [Member]	Old Ginkgo Common Stock [Member] Revision of Prior Period, Adjustment [Member]	Common Stock [Member]	Common Stock [Member] Revision of Prior Period, Adjustment [Member]	Common Stock [Member] Series E Convertible Preferred Stock [Member]	Common Stock [Member] Series D & B Convertible Preferred Stock [Member]	Treasury Stock [Member]	Treasury Stock [Member] Previously Reported [Member]	Treasury Stock [Member] Revision of Prior Period, Adjustment [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Previously Reported [Member]	Additional Paid-in Capital [Member] Revision of Prior Period, Adjustment [Member]	Additional Paid-in Capital [Member] Series E Convertible Preferred Stock [Member]	Retained Earnings [Member]	Retained Earnings [Member] Previously Reported [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Noncontrolling Interest [Member] Previously Reported [Member]
Balance as of December 31, 2019 (as previously reported) at Dec. 31, 2018	$ 213,432,000	$ 213,432,000				$ 86,000	$ (86,000)	$ 116,000	$ 116,000			$ (24,453,000)	$ (24,449,000)	$ (4,000)	$ 450,391,000	$ 450,268,000	$ 123,000		$ (221,942,000)	$ (221,942,000)		$ 9,320,000	$ 9,320,000
Beginning balance (Shares) at Dec. 31, 2018				14,943,599	(14,943,599)								(756,633)	(36,379,256)
Balance as of December 31, 2019 (as previously reported) at Dec. 31, 2018				$ 149,000	$ (149,000)
Beginning balance (Shares) at Dec. 31, 2018						8,555,710	(8,555,710)	1,153,356,703	1,153,356,703			(37,135,889)
Exercise of stock options								$ 500,621,000
Conversion of convertible promissory notes into Series E convertible preferred stock	211,608,000									$ 7,000					211,601,000
Conversion of convertible promissory notes into Series E convertible preferred stock, Share										69,151,117
Retirement of treasury stock								$ (4,000)				$ 24,861,000			(24,857,000)
Retirement of treasury stock, Share								(37,626,694)				37,626,694
Vesting of restricted stock awards								367,858
Beneficial conversion feature of convertible promissory notes	12,651,000														(12,651,000)
Repurchase of common stock	408,000											$ (408,000)
Repurchase of common stock, Share												(490,805)
Issuance of warrants to purchase Series D convertible preferred stock	150,000														150,000
Issuance of Series E convertible preferred stock, net of issuance costs			$ 208,801,000							$ 7,000								$ 208,794,000
Issuance of Series E convertible preferred stock, net of issuance costs										69,812,427
Stock-based compensation expense	771,000														771,000
Net loss	(119,857,000)																		(119,327,000)			(530,000)
Balance as of December 31, 2020 at Dec. 31, 2019	501,853,000							$ 126,000							834,206,000				(341,269,000)			8,790,000
Ending balance (Shares) at Dec. 31, 2019								1,255,562,032
Exercise of stock options	26,000							$ 1,921,941,000							26,000
Vesting of restricted stock awards								256,838
Issuance of Series E convertible preferred stock, net of issuance costs			$ 94,420,000							$ 3,000								$ 94,417,000
Issuance of Series E convertible preferred stock, net of issuance costs										30,855,065
Stock-based compensation expense	476,000														476,000
Net loss	(126,723,000)																		(126,609,000)			(114,000)
Balance as of December 31, 2020 at Dec. 31, 2020	470,052,000							$ 129,000							929,125,000				(467,878,000)			8,676,000
Ending balance (Shares) at Dec. 31, 2020								1,288,595,876
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	$ 461,376,000
Exercise of stock options, Share	10,969,639
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	$ 176,000							$ 9,000							167,000
Issuance of common stock upon exercise of stock options and vesting of restricted stock units								91,080,290
Tax withholdings related to net share settlement of equity awards	(9,463,000)														(9,463,000)
Tax withholdings related to net share settlement of equity awards								(797,313)
Founder shares repurchase	24,998,000														(24,998,000)
Founder shares repurchase, Share								(2,707,280)
Vesting of restricted stock awards															(4,000)
Vesting of restricted stock awards								38,798,801
Issuance of warrants to purchase Series D convertible preferred stock	300,000														300,000
Issuance of common stock for a business acquisition	15,160,000														15,160,000
Issuance of common stock for a business acquisition								1,633,937
Issuance of Series E convertible preferred stock, net of issuance costs										408,497	1,013,708
Issuance of common stock upon reverse recapitalization, net of offering costs (Note 3)	1,509,629,000							$ 19,000							1,509,610,000
Issuance of common stock upon reverse recapitalization, net of offering costs (Note 3), Share								193,365,636
Assumption of Public and Private Placement Warrants	(194,453,000)														(194,453,000)
Non-controlling interest contributions	59,933,000																					59,933,000
Stock-based compensation expense	1,579,400,000														1,579,400,000
Foreign currency translation	(1,715,000)																				$ (1,715,000)
Net loss	(1,836,642,000)																		(1,830,047,000)			(6,595,000)
Balance as of December 31, 2020 at Dec. 31, 2021	$ 1,567,379,000							$ 161,000							$ 3,804,844,000				$ (2,297,925,000)		$ (1,715,000)	$ 62,014,000
Ending balance (Shares) at Dec. 31, 2021								1,611,392,152